Showing 1541-1550 of 2007 results for "".
- Aesthetic Society Names New Presidenthttps://modernaesthetics.com/news/aesthetic-society-names-new-president/2473569/The Aesthetic Society announced the appointment of Kiya Movassaghi, MD, DMD, FACS, a board-certified plastic surgeon from Eugene, Oregon, as its president, saying his leadership will focus on strategically fortifying The Society's position as the global leader in education and innov
- Elevai Labs Eyes Obesity Treatment Market with Myostatin Inhibitorshttps://modernaesthetics.com/news/elevai-labs-expands-pipeline-eyes-obesity-treatment-market-with-myostatin-inhibitors/2473568/Elevai Labs, Inc. announced that it has acquired exclusive rights to two assets (EL-22 and EL-32) aimed at preventing muscle loss and treating obesity, according to a company press release. The new assets, according to the company, involve engineered probiotics expressing myostatin and
- New Breast Implant Is MDR-Approvedhttps://modernaesthetics.com/news/new-breast-implant-is-mdr-approved/2473566/The new European Medical Device Regulation (MDR) has approved a breast implant for the first time, according to a press release from GC Aesthetics® (GCA®). Under the new MDR rules set forth by the European Union (EU), medical standards are updated rigorousl
- Tell-All Tribune Explores Most Important Topics in Aesthetic Medicinehttps://modernaesthetics.com/news/tell-all-tribune-explores-most-important-topics-in-aesthetic-medicine/2473565/The inaugural Tell-All Tribune: An Aesthetic Think Tank was held in Fort Lauderdale, Florida, from April 18-20, and could perhaps be summed up in six words from course director Shino Bay Aguilera, DO: “What we do goes beyond vanity." Along with fellow course directors Michell
- Zubritsky Joins Detergent Brand as Chief Dermatology Advisorhttps://modernaesthetics.com/news/zubritsky-joins-detergent-brand-as-chief-dermatology-advisor/2473562/Board-certified dermatologist and popular social media influencer Lindsey Zubritsky, MD, FAAD, has joined all® free clear as
- FDA Issues Alert for Counterfeit Botox Across Multiple U.S. Stateshttps://modernaesthetics.com/news/fda-issues-alert-for-counterfeit-botox-across-multiple-us-states/2473560/The U.S. Food and Drug Administration (FDA) has issued an alert regarding counterfeit botulinum toxin that has been detected in several states. The agency issued a statement on April 16 noting that it is aware of the issue and is working with the Centers for Disease Control (CDC),
- Murad Alam, MD, FAAD, Elected American Academy of Dermatology President for 2026https://modernaesthetics.com/news/murad-alam-md-faad-elected-american-academy-of-dermatology-president-for-2026/2473558/Chicago-based board-certified dermatologist Murad Alam, MD, FAAD, has been elected to lead the American Academy of Dermatology (AAD). He will be installed as president-elect in March 2025 and hold the office of president for 1 year beginning in March 2026. AAD is the world’s large
- Botulism-Like Symptoms Linked to Suspected Fake Cosmetic Injections in Illinoishttps://modernaesthetics.com/news/botulism-like-symptoms-linked-to-suspected-fake-cosmetic-injections-in-illinois/2473557/The Illinois Department of Public Health (IDPH) has issued a warning to healthcare facilities, particularly hospital ERs, urging heightened vigilance for patients exhibiting symptoms resembling botulism. The advisory follows the identification of a clus
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we